Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,001
Total Claims
$1.1M
Drug Cost
782
Beneficiaries
$1,456
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-25%
Opioid rate vs peers
1.7% vs 2.2% avg
+3%
Cost per patient vs peers
$1,456 vs $1,411 avg
+14%
Brand preference vs peers
12.1% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.7%
Opioid Rate
168
Opioid Claims
$12K
Opioid Cost
6.5%
Long-Acting Rate
Brand vs Generic
Brand: 1,193 claims · $890K
Generic: 8,687 claims · $240K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 128 | $210K |
| Apixaban | 78 | $83K |
| Mirabegron | 36 | $48K |
| Insulin Glargine,hum.Rec.Anlog | 46 | $45K |
| Rivaroxaban | 31 | $41K |
| Sitagliptin Phosphate | 24 | $40K |
| Dulaglutide | 26 | $29K |
| Fluticasone Propion/Salmeterol | 20 | $24K |
| Insulin Aspart | 17 | $23K |
| Empagliflozin | 14 | $19K |
| Insulin Detemir | 14 | $18K |
| Fluticasone/Vilanterol | 17 | $15K |
| Insulin Lispro | 11 | $14K |
| Budesonide/Formoterol Fumarate | 13 | $13K |
| Evolocumab | 15 | $12K |
Prescribing Profile
Patient Profile
75
Avg Age
70%
Female
1.38
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About